Fragment-Based Strategy for Investigating and Suppressing the Efflux of Bioactive Small Molecules.
Membrane protein-mediated drug efflux is a phenomenon that compromises our ability to treat both infectious diseases and cancer. Accordingly, there is much interest in the development of strategies for suppression of the mechanisms by which therapeutic agents are effluxed. Here, using resistance to the cyclic acyldepsipeptide (ADEP) antibacterial agents as a model, we demonstrate a new counter-efflux strategy wherein a fragment of an actively exported bioactive compound competitively interferes with its efflux and potentiates its activity. A fragment comprising the N-heptenoyldifluorophenylalanine side chain of the pharmacologically optimized ADEPs potentiates the antibacterial activity of the ADEPs against actinobacteria to a greater extent than reserpine, a well-known efflux inhibitor. Beyond their validation of a new approach to studying molecular recognition by drug efflux pumps, our findings have important implications for killing Mycobacterium tuberculosis with ADEPs and reclaiming the efficacies of therapeutic agents whose activity has been compromised by efflux pumps.
Department of Chemistry, Brown University , 324 Brook Street, Providence, Rhode Island 02912, United States.
Corey L
CL
Compton
Department of Chemistry, Brown University , 324 Brook Street, Providence, Rhode Island 02912, United States.
Daniel W
DW
Carney
Department of Chemistry, Brown University , 324 Brook Street, Providence, Rhode Island 02912, United States.
Patrice V
PV
Groomes
Department of Chemistry, Brown University , 324 Brook Street, Providence, Rhode Island 02912, United States.
Jason K
JK
Sello
Mycobacterium; Streptomyces; cyclic acyldepsipeptide (ADEP); drug resistance; efflux